29.01.2015 Views

Conference PPT (5 MB) - Institute for Oral Health

Conference PPT (5 MB) - Institute for Oral Health

Conference PPT (5 MB) - Institute for Oral Health

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Oral</strong> <strong>Health</strong> in Aging America:<br />

<strong>Oral</strong> –Systemic <strong>Health</strong> Linkages<br />

Linda C. Niessen, DMD<br />

LCN


Acknowledgements<br />

• Baylor College of Dentistry, Texas A&M HSC<br />

• DENTSPLY International


VA North Texas <strong>Health</strong> Care System


Purpose<br />

• Examine the oral health-<br />

systemic health link and the<br />

role that oral inflammation<br />

can play on systemic<br />

diseases<br />

• Discuss the most common<br />

medical conditions and<br />

medications and their<br />

effects on oral health care<br />

• Identify future oral health<br />

system needs to insure oral<br />

health in an aging America


Thesis<br />

• The mouth is connected to the<br />

rest of the body.<br />

– New research is identifying the<br />

effects of oral infection and<br />

inflammation on target organs.<br />

• Caring <strong>for</strong> older adults makes<br />

these linkages readily<br />

apparent.<br />

– Dental professionals need<br />

greater interaction with the<br />

overall health care system.<br />

• Patients are beginning to<br />

understand the relationship<br />

between oral health and<br />

systemic health.


Thesis<br />

• <strong>Oral</strong>–systemic link will re-assert<br />

the importance and value of<br />

prevention of oral diseases.<br />

– <strong>Oral</strong> diseases play a pivotal role in chronic<br />

disease management<br />

• Patients value preventive care,<br />

even when they don’t t comply.<br />

• Preventive care tells patients<br />

you value their future,<br />

regardless of how long it is!


Changing Demographics and<br />

Expectations<br />

• This is not your mother’s<br />

aging society<br />

• Baby boomers will redefine<br />

what it means to age<br />

successfully, gracefully!<br />

• It includes maintaining<br />

good health and good oral<br />

health<br />

• Older adults will seek<br />

in<strong>for</strong>mation about their<br />

health from a variety of<br />

sources


Life Expectancy of Women and Men, US<br />

20<br />

15<br />

10<br />

5<br />

0<br />

65<br />

years<br />

75<br />

years<br />

85<br />

years<br />

95<br />

years<br />

100<br />

years<br />

Men-Black 14.5 9.4 5.7 3.6 2.9<br />

Men-White 16.3 10.1 5.6 3.1 2.4<br />

Women-Black 17.4 11.2 6.5 3.6 2.7<br />

Women-White 19.2 12.1 6.7 3.5 2.7<br />

Source: Centers <strong>for</strong> Disease Control and Prevention, US National Center <strong>for</strong> <strong>Health</strong><br />

Statistics, Life Expectancy by Age, Race and Sex in the United States, 2000.


Successful Aging<br />

• Engages with life<br />

• Avoids disease<br />

• Maintains high<br />

cognitive and<br />

physical function


Successful Aging<br />

100%<br />

80%<br />

70%<br />

60%<br />

40%<br />

30%<br />

20%<br />

0%<br />

Factors<br />

Lifestyle<br />

Genetics


Genes are not your destiny


Principles of Geriatric Medicine<br />

• Age Related Changes<br />

• Disease Related Changes<br />

• Atypical Presentation of Disease<br />

• Multiple Pathology<br />

• Under Reporting of Disease Symptoms<br />

• Functional Status Assessment<br />

• Role of Interdisciplinary Team


Multiple Pathology<br />

• Heart disease<br />

• Hypertension<br />

• Arthritis<br />

• Stroke<br />

• Diabetes<br />

• Depression…<br />

– be<strong>for</strong>e you even<br />

look in the mouth<br />

Your initial medical history and medication history will<br />

take longer!


Chronic Diseases in Older Adults<br />

• Top 5 Causes of Death<br />

– Heart Disease<br />

– Cancer<br />

– Stroke<br />

– Alzheimer’s s disease<br />

– Respiratory disease<br />

• Top 5 Chronic Diseases<br />

– Arthritis<br />

– Hypertension<br />

– Heart Disease<br />

– Hearing Impairments<br />

– Cataracts<br />

What we die from!<br />

What we live with!


Heterogeneity of Elders<br />

• Active Elders 85%<br />

• Chronically Ill 10%<br />

• Nursing Home 5%<br />

Residents<br />

The differences in status often result from the number of chronic<br />

diseases and ability to maintain function, e.g. activities of daily<br />

living.


Cardiovascular Disease in the Elderly<br />

• Hypertension<br />

• Myocardial Infarct<br />

• Congestive Heart Failure<br />

• Atrial Fibrillation<br />

• Conduction System<br />

Defects<br />

• Valvular Heart Disease<br />

Does your health history <strong>for</strong>m capture these different <strong>for</strong>ms of<br />

heart disease and the medications taken to manage them


Cardiac Disease and Treatment<br />

• Organ damage due to<br />

hypertension<br />

• Muscle damage due to<br />

decreased blood supply<br />

(angina, MI)<br />

• Conduction system<br />

defect (arrythmias)<br />

• Pump malfunction (CHF)<br />

• Atrial fibrillation<br />

• Valvular disease<br />

• Diuretics, ACEI, CCB,<br />

β-blockers<br />

• NTG, CABG<br />

• Pacemaker, implanted<br />

defibrillation<br />

• Digoxin<br />

• Plavix (clopigrel), ASA<br />

• Prosthetic Valves


<strong>Oral</strong> Examination<br />

• Caries<br />

• Periodontal disease<br />

• <strong>Oral</strong> soft tissue<br />

lesion<br />

• Missing teeth


Cardiovascular Disease and Periodontal<br />

Infections<br />

• Evidence continues to mount that periodontal<br />

infections play a contributory role in the development<br />

of cardiovascular disease (remember Dr. Roizen’s<br />

video yesterday)<br />

• Are we ready to recommend and reimburse<br />

periodontal treatment in the patient with moderate-<br />

severe, localized or generalized periodontal disease<br />

as part of the management of his/her cardiovascular<br />

disease<br />

Source: R Demmer and M. Desvarieux. Periodontal<br />

infections and cardiovascular disease. JADA 137: 14s-<br />

20s, October, 2006.


Dental Implications of<br />

Cardiovascular Treatment<br />

• Physician consult<br />

– When in doubt, ask<br />

• Hypertension<br />

– Check BP at each dental visit<br />

• Medications<br />

– Xerostomia –BB, ACEI, CCB, ARB<br />

– Gingival Overgrowth-nifedipine<br />

– Lichenoid reactions<br />

– Bleeding – Plavix, Aspirin<br />

• Valvular Disease<br />

– New SBE Guidelines


CARDIAC CONDITIONS FOR WHICH PROPHYLAXIS FOR<br />

DENTAL PROCEDURES IS RECOMMENDEDFOR<br />

PREVENTION OF BACTERIAL ENDOCARDITIS*<br />

• Prosthetic cardiac valve<br />

• Previous infective endocarditis<br />

• Congenital Heart Disease (CHD)<br />

– Unrepaired cyanotic CHD, including palliative shunts and conduits<br />

– Completely repaired congenital heart defect with prosthetic material or device,<br />

whether placed by surgery or by catheter intervention, during the e first 6<br />

months after the procedure (endothelialization occurs within 6 month m<br />

of<br />

procedure)<br />

– Repaired CHD with residual defects at the site or adjacent to the e site of a<br />

prosthetic patch or prosthetic device (which inhibits endothelialization)<br />

lization)<br />

• Cardiac transplant recipients who develop cardiac valvulopathy<br />

*Except <strong>for</strong> the cardiac conditions listed above, antibiotic prophylaxis is no longer<br />

recommended <strong>for</strong> any cardiac condition or problem.<br />

Source: Current American Heart Association Guidelines<br />

Published May 8, 2007, Circulation, , Vol. 115.


Dental Procedures and<br />

Rational <strong>for</strong> Revisions<br />

• All dental procedures that involve manipulation of gingival<br />

tissue or the periapical region of the teeth or per<strong>for</strong>ation of<br />

the oral mucosa (not needed <strong>for</strong> LA through non-infected<br />

tissue, radiographs, placement of and/or adjustment of<br />

removable or orthodontic appliances, shedding of 1 o teeth)<br />

• Infective endocarditis (IE) more likely to result from frequent<br />

exposure to random bacteremias associated with daily<br />

activities<br />

• Maintenance of optimal oral health & hygiene may reduce<br />

incidence of bacteremia from daily activities and may be<br />

more important than prophylactic antibiotics <strong>for</strong> a dental<br />

procedure to reduce the risk of IE<br />

Source: Wilson, et al. Prevention of infective endocarditis: Guidelines from<br />

the American Heart Association. JADA 138:739-760, 760, June 2007.


Cerebrovascular Accident<br />

• 500,000 new cases each<br />

year<br />

• 3rd most common cause<br />

of death<br />

• Can be thrombolytic or<br />

hemorrhagic<br />

• Most common sequelae-<br />

motor loss of dominant<br />

side


Cerebrovascular Accident<br />

• Study reported a 400%<br />

increase in stroke risk<br />

associated with<br />

periodontitis but found<br />

no relationship between<br />

caries and stroke.<br />

• <strong>Oral</strong> inflammation plays<br />

a role in the mechanism<br />

of action<br />

Source: Grau AJ, Becher H, Ziegler CM et al. Periodontal disease<br />

as a risk factor <strong>for</strong> ischemic stroke. Stroke 35(2): 496-501, 2004.


Dental Implications of CVA<br />

• Transportation to office<br />

• Dominant hand function and<br />

oral self care abilities<br />

• Aphasia<br />

• Depression<br />

• Transfer to dental chair<br />

• Loss of oral motor function<br />

• Post-op op meds:<br />

– Anti-coagulants<br />

– Bleeding-need need INR data<br />

– Gingival overgrowth


•Dilantin (Anticonvulsant)<br />

•Nifedipine (Calcium<br />

Channel Blocker)<br />

•Cyclosporine<br />

(Immunosuppressive)<br />

•New BP medications<br />

• Isn’t dental care<br />

medically necessary<br />

after a CVA as part of<br />

the management


Diabetes Mellitus<br />

• >9% of population<br />

• Onset<br />

– Type I-5-10% I<br />

(Juvenile)<br />

– Type II- 90-95% 95% (Adult)<br />

• Medications<br />

– <strong>Oral</strong> hypoglycemic<br />

– Insulin<br />

• Research on diabetes<br />

and perio disease most<br />

developed


Dental Implications<br />

• Higher risk of infections<br />

– periodontal disease<br />

– oral candida<br />

• Research is showing that when<br />

diabetics have their periodontal<br />

infections treated, their insulin<br />

requirements decrease<br />

• Doesn’t t this suggest that<br />

treatment of periodontal<br />

infections is part of the<br />

management of the diabetic<br />

patient


Source: Considerations <strong>for</strong> treating the dental patient with diabetes.<br />

American Dental Association, 2003.<br />

Considerations <strong>for</strong> Dental Treatment<br />

• More frequent recall<br />

• Emphasis on soft<br />

tissue management<br />

– SRP prn<br />

– Antiobiotic treatment<br />

• AM appointments (or<br />

when insulin at peak)


Diabetes – The poster disease <strong>for</strong><br />

reconnecting reimbursement <strong>for</strong><br />

oral care with medical care<br />

• In the management of the<br />

diabetic patient, why can<br />

the diabetic patient have<br />

his:<br />

– blood glucose managed<br />

– cardiovascular disease<br />

treated<br />

– eye disease resolved<br />

– foot care evaluated<br />

– periodontal infections<br />

ignored


Osteoporosis<br />

• Loss of bone mass and<br />

architecture<br />

• Increased risk of<br />

fracture<br />

• Female to male ratio<br />

4:1<br />

• 1.5 million fractures<br />

annually


Treatment of Osteoporosis<br />

• Vitamin D<br />

• Calcium<br />

• Weight bearing<br />

exercise (not<br />

swimming)<br />

• Strength training<br />

• Fluoride (Pak et al)<br />

• Bisphosphonates<br />

– Fosamax, Aredia,<br />

Boniva


Bisphosphonate Induced<br />

Osteonecrosis of the Jaw (ONJ)<br />

Slide courtesy of Dr. Harry<br />

Gilbert, VAMC Houston<br />

Zolendronic acid (Zometa) - IV<br />

Novartis<br />

Pamidronate (Aredia) - IV<br />

Novartis<br />

Alendronate (Fosamax) - oral<br />

Merck<br />

Risendronate (Actonel) - oral<br />

Procter and Gamble<br />

Pharmaceuticals


Risk of Osteonecrosis of the Jaw <strong>for</strong><br />

Patients Taking Bisphosphonates<br />

• Risk <strong>for</strong> developing ONJ with IV bisphosphonates<br />

is ~10-12% 12% (multiple myeloma, breast CA-any CA<br />

metastatic to bone; drugs control osteoclasts).<br />

• Risk <strong>for</strong> developing ONJ with oral bisphosphonates<br />

is less than 1%.<br />

• Lower risk <strong>for</strong> ONJ in first 6 months of IV therapy;<br />

first 3 years of oral treatment.<br />

Source: Migliorati, CA, JA Casiglis, J. Epstein, PI Jacobsen, MA Siegel, SB Woo.<br />

Managing the care of patents with bisphospnhonate-associated associated osteonecrosis:<br />

An American Academy of <strong>Oral</strong> Medicine position paper. JADA 136(12):1658<br />

):1658-68, 68,<br />

2005.


Strategies <strong>for</strong> Patients on<br />

• Take a good history<br />

Bisphosphonates<br />

– <strong>Oral</strong> bisphosphonates < IV<br />

Bisphosphonates<br />

– <strong>Oral</strong> bisphosphonates < 3 yrs<br />

• Consult with patient’s s MD<br />

• Treatment Planning<br />

– In<strong>for</strong>med consent<br />

– Tooth conserving procedures<br />

(endo v. extraction)<br />

• Prevention<br />

– Good oral hygiene<br />

– Regular dental visits<br />

Slide courtesy of Dr. Richard<br />

Davis, Cleveland, VAMC<br />

Source: Robert Marx, Bisphosphonate-induced Osteonecrosis of the Jaw, 2006.


Rheumatoid Arthritis and<br />

Osteoarthritis<br />

• Inflammatory<br />

mechanism<br />

• Disabilities<br />

– How does patient get<br />

to your office<br />

– Evaluate oral hygiene<br />

self care<br />

• Medications<br />

– Pain meds


Professional <strong>Oral</strong> Care<br />

• Control biofilms with<br />

scaling and root planing<br />

based on patient’s s needs -<br />

PRN<br />

• Rein<strong>for</strong>ce daily oral self<br />

care<br />

• Will require more of the<br />

dental hygienist’s s time<br />

• Consider reimbursing <strong>for</strong><br />

time rather than CPT code<br />

– Or add co-morbities


Degenerative Joint Disease<br />

• Can lead to joint<br />

replacement<br />

• Can have total joint<br />

replaced or pins placed<br />

to repair fractures<br />

• Joint replacements<br />

require antibiotics <strong>for</strong><br />

high risk patients


ADA Guidelines on<br />

Prophylactic Antibiotics <strong>for</strong><br />

Patients With Prosthetic Joints<br />

If:<br />

<strong>Health</strong>y<br />

Risk Factors<br />

NO<br />

YES<br />

Source: Antibiotic prophylaxis <strong>for</strong> dental patients with total<br />

joint replacements. JADA, 134:895-898 July 2003.


Patients at potential increased risk<br />

of hematogenous total joint<br />

• All patients during first two years<br />

following joint replacement<br />

• Immunocompromised/immuno-<br />

suppressed patients<br />

– Inflammatory arthropathies: rheumatoid arthritis,<br />

systemic lupus erythematosus<br />

– Drug- or radiation-induced induced immunosuppression<br />

• Patients with co-morbidities


Patients at potential increased risk<br />

of hematogenous total joint<br />

• Patients with co-morbidities<br />

– Previous prosthetic joint infections<br />

– Malnourishment<br />

– Hemophilia<br />

– HIV Infection<br />

– Insulin-dependent (Type 1) diabetes<br />

– First 2 years following joint placement<br />

– Malignancy<br />

Source: Antibiotic prophylaxis <strong>for</strong> dental patients with total<br />

joint replacements. JADA, 134:895-898 July 2003.


Medication Use<br />

• OTC Medications<br />

(not perceived as<br />

medicines or<br />

serious)<br />

• Multiple<br />

prescription<br />

medications<br />

• Compliance<br />

• Interactions<br />

• Change frequently


Medications<br />

• Prescription Meds<br />

– Anti-hypertensives<br />

– Diabetic meds<br />

– Cholesterol<br />

lowering<br />

– Cardiac meds<br />

– NSAID (anti-<br />

arthritics)<br />

– Anti-depressants<br />

• OTC Meds<br />

– Antacids (sugar<br />

content)<br />

– Analgesics (ASA)<br />

– Vitamins (E and C)<br />

– Herbal<br />

Supplements<br />

» Glucosamine<br />

» Chondroitin sulfate<br />

» Co-enzyme Q<br />

Bleeding and oral dryness among concerns with multiple<br />

medication use.


Saliva: A Natural Resource


Signs of Xerostomia<br />

• Increased caries,<br />

especially root caries<br />

• Epithelial atrophy<br />

• Inflammatory fissuring<br />

• <strong>Oral</strong> candida infection


Differential Diagnosis of<br />

Alterations in Salivary Flow<br />

• Multiple medications<br />

• Head and neck<br />

radiation<br />

• Endocrine changes<br />

• Primary salivary gland<br />

pathology


Medications Causing <strong>Oral</strong> Dryness<br />

• Antidepressants<br />

• Antihistamines<br />

• Antihypertensives<br />

• Antineoplastics<br />

• Antipsychotics<br />

• Antispasmodics<br />

• Decongestants<br />

• Diuretics<br />

• Tranquilizers<br />

Medications taken on a regular basis <strong>for</strong> a<br />

long time cause more oral dryness.


Treatment Options<br />

• Hydration<br />

– Older adults often<br />

don’t t thirst<br />

– Frequent liquids<br />

– Reduce liquids<br />

containing caffeine or<br />

alcohol<br />

• Mechanical<br />

– Chewing xylitol gum


Johnson JT,et al. <strong>Oral</strong> pilocarpine in post-irradiation xerostomia in patients<br />

with head and neck cancer. New Engl J Med, 329:390, 1993<br />

Prescription Medications<br />

• Pilocarpine<br />

(Salagen®)<br />

– 5 mg. tid (not to<br />

exceed 30 mg/day)<br />

– Treat <strong>for</strong> minimum<br />

of 90 days<br />

– Contraindications:<br />

Asthma, glaucoma<br />

– Side effects:<br />

sweating<br />

• Cevimeline<br />

(Evoxac)<br />

– 30-60 mg. Tid (not<br />

to exceed 180<br />

mg/day)<br />

– Contraindications:<br />

asthma, glaucoma,<br />

severe COPD<br />

– Side effects:<br />

sweating


Salivary Substitutes<br />

• Provide palliative<br />

relief from oral<br />

dryness<br />

• Replace minerals<br />

and enzymes in<br />

saliva<br />

• Can use prn<br />

• Contraindicated-<br />

alcohol-based<br />

mouthrinses<br />

• Ingredients include:<br />

– ions: Na, Cl, Mg, F, Ca,<br />

Phosphates<br />

– flavoring: lemon, mint,<br />

neutral<br />

– lubricants/sweeteners-<br />

glycerin, sorbitol,<br />

xylitol<br />

– preservative-paraben<br />

paraben<br />

– enzymes- lactoferrins,<br />

peroxidases, etc


Risk Assessment<br />

Who is susceptible<br />

LCN


Risk Assessment<br />

There are no generic<br />

patients.


Risk Assessment<br />

<strong>Oral</strong>-systemic health<br />

research is<br />

demonstrating the<br />

importance of oral<br />

inflammation and<br />

that oral care is<br />

critical to the<br />

management of<br />

chronic diseases.


Maintaining teeth is<br />

sometimes just as<br />

difficult- but plays a<br />

key role in daily<br />

eating, speaking,<br />

smiling, swallowing.<br />

Losing teeth is<br />

psychological and<br />

physically difficult.


Conclusions<br />

• Mouth is connected to the rest<br />

of the body.<br />

• Older adults demonstrate the<br />

connection between systemic<br />

diseases and medications on<br />

oral health more readily than<br />

other populations<br />

• Presence of oral infection &<br />

inflammation can exacerbate<br />

systemic illnesses and vice<br />

versa<br />

• We need a social marketing<br />

campaign about the<br />

relationship b/w oral disease &<br />

systemic diseases


Conclusions<br />

• <strong>Oral</strong> diseases can play a<br />

pivotal role in chronic disease<br />

management.<br />

• High level of interaction<br />

between the dental care<br />

system and the medical care<br />

system is critical to healthy<br />

aging.<br />

• Linking financing &<br />

reimbursement between oral<br />

care system & medical system<br />

may improve system<br />

efficiencies and lower costs<br />

• Very vulnerable continue to<br />

have the least access to oral<br />

health care


What would you do differently<br />

as a result of this conference<br />

• Will it be to control your own aging through gene expression<br />

and reduce your stress per Dr. Roizen and Dr. Singer<br />

• Become an advocate and care <strong>for</strong> more older adults per Dr.<br />

Shuman<br />

• Examine new methods of financing & reimbursement per Dr.<br />

Jones<br />

• Educate next generation of dental and medical professionals<br />

together per Dr. Berkey<br />

• Develop novel community delivery programs per Dr.<br />

Helgeson<br />

• Let your voice be heard and insure that oral health is included<br />

in the debate on universal health coverage in the US per Dr.<br />

Olsen


“May you die very young,<br />

at a very old age.”

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!